The outcome of the analysis of health data related to 107,598 patients with Parkinson’s disease.
American researchers analyzed the data related to 107,598 patients with Parkinson’s disease, included in clinical trials to establish their risk of developing a malignancy. They found that such risk was 27% lower vs controls without the disease. The reduction in risk increased up to 31% when skin cancer was excluded and regarded both smoking related (-39%) and non smoking related cancers (-24%).
Source: Bajaj A et al Cancer causes control online 7 January 2010